
Diabetic Retinopathy
Latest News

CME Content


How autonomous diagnostics for DR gave a ‘jump-start’ to AI in ophthalmology

Subthreshold laser may reduce intravitreal injections for DME

Connect the dots: Diagnosing, managing multifocal choroiditides

Coming to terms with ‘ultra-widefield’ and ‘widefield’ imaging

Is deep learning the future of diabetic retinopathy screening?

Tracking anti-VEGF use among Medicare Part B beneficiaries



ICYMI: Dr. Singh shares the take-home message from his 2019 presentation

ICMYI: Dr. Wykoff discusses results from his ASRS presentation

Anti-VEGFs pose no additional risk of SAEs over other therapies


Obesity + diabetic retinopathy: Korean study explores inverse association




Image-reading accuracy Increases with deep-learning DR algorithms

UWF imaging contributes to earlier disease detection
New research confirms agreement with 7 standard field imaging

FDA decision changes scope of healthcare delivery; increases patient access to early detection of DR

Novel treatments in pipeline for diabetic eye disease
Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.

A study shows Alzheimer’s disease biomarkers in the vitreous


Microaneurysm turnover predicts diabetic retinopathy progression
Micoaneurysm turnover in the early stages of diabetic retinopathy predicts how much the disease will progress, according to researchers.

Review of the epidemiology of diabetic retinopathy
The prevalence of visual impairment and blindness caused by diabetic retinopathy is increasing worldwide. Early recognition, perhaps via a screening programme, and timely management would be of benefit.




























